首页> 美国卫生研究院文献>BMC Nephrology >A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status

【2h】

A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status

机译：铁缺乏的静脉注射铁（FDI）的多中心前瞻性双盲随机对照试验但不具有血糖患者的慢性肾病患者功能状态

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The online version contains supplementary material available at 10.1186/s12882-021-02308-y.

机译：在线版本包含10.1186 / s12882-021-02308-y提供的补充材料。

著录项

期刊名称 BMC Nephrology
作者
S. Bhandari; V. Allgar; A. Lamplugh; I. Macdougall; P. A. Kalra;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 12
原文格式 PDF
正文语种
中图分类泌尿科学（泌尿生殖系疾病）;小儿泌尿科学;肾疾病;
关键词
Anaemia; Chronic kidney disease (CKD); Ferric derisomaltose; Iron deficiency; Randomised trial;

机译：贫血;慢性肾病（CKD）;铁甲状腺酸钠;铁缺乏;随机试验;

相似文献

外文文献
中文文献
专利

1. Rationale and design of the AFFIRM‐AHF trial: a randomised, double‐blind, placebo‐controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron‐deficient patients admitted for acute heart failure [J] . Ponikowski Piotr, Kirwan Bridget‐Anne, Anker Stefan D., European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology . 2019,第12期

机译：肯定的理由和设计肯定 - AHF试验：随机，双盲，安慰剂对照试验，比较静脉内碳乳菌菌对急性心脏衰竭的铁缺乏患者住院治疗和死亡率的影响
2. A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiencyn anaemia of non-dialysis-dependent chronic kidney disease patients [J] . Simon D. Roger Nephrology Dialysis Transplantation . 2011,第5期

机译：比较静脉内羧化麦芽糖铁和口服铁治疗非透析依赖型慢性肾脏病患者铁缺乏症贫血的随机对照试验
3. A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients. [J] . Qunibi WY, Martinez C, Smith M, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association . 2011,第5期

机译：一项随机对照试验，比较了静脉内羧化麦芽糖铁和口服铁剂治疗非透析依赖性慢性肾脏病患者的铁缺乏性贫血。
4. Iron Metabolism in Chronic Kidney Disease Patients [C] . Hirokazu Honda, Nozomu Hosaka, Tomas Ganz, Nihon To?seki Igakkai., Gakujutsu Shu?kai So?kai . 2019

机译：慢性肾病患者的铁代谢
5. Utilization patterns and economic impact of IV iron and erythropoiesis stimulating agents in chronic kidney disease patients: A multi-hospital study [D] . Joshi, Avani D. 2010

机译：慢性肾脏病患者静脉输注铁和促红细胞生成素刺激剂的使用模式和经济影响：一项多院研究
6. A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients [O] . Wajeh Y. Qunibi, Carlos Martinez, Mark Smith, -1

机译：比较静脉内羧化麦芽糖铁和口服铁剂治疗非透析依赖型慢性肾脏病患者的铁缺乏性贫血的随机对照试验
7. A Multicenter Prospective Double Blinded Randomized Controlled Pilot Trial of Intravenous Iron (Ferric Derisomaltose (FDI)) in Iron Deficient but not Anemic Patients with Chronic Kidney Disease on Functional Status. [O] . Sunil Bhandari, Victoria Allgar, Archie Lamplugh, 2020

机译：铁缺乏静脉铁（铁甲状铁糖糖（FDI））的多中心前瞻性双盲随机对照试验试验试验，但不具有血糖患者慢性肾病患者功能状态。

A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status

摘要

著录项

相似文献

相关主题

期刊订阅